a practical extraction method was developed, and the bioactivities in patients with chronic renal failure receiving hemodialysis were compared with those in normal subjects. Serum samples were obtained from 12 normal subjects and 12 patients with chronic renal failure receiving hemodialysis. TSH was extracted from the serum using anti-human TSH monoclonal antibody coated tubes, followed by elution with 2.0 mol/l guanidine-HCl solution (pH 3.2) . After the eluate had been dialyzed against phosphate buffered saline (pH 7.4) and again against TRIS\x=req-\ HCl solution (pH 7.4) and then lyophilized, it was reconstituted with hypotonic Hanks' solution. Bioassay for TSH was performed by measuring the levels of cAMP released into the medium from cultured FRTL-5 cells incubated with the extract. The mean immunoreactive recovery rates of TSH from the serum in normal subjects and patients with chronic renal failure were about 42% (\ m=+-\6) and 40% (\ m=+-\ 2), respectively. The present bioassay was sufficiently sensitive to detect a serum TSH level of 1.0 mU/l when 3.0 ml of serum was used. Extracts from standard sera at concentrations ranging from 1.0 to 10 mU/l added to the culture medium caused significant linear increases in cAMP production. Based (8) . After the dialysates had been lyophilized, they were reconstituted with 1.3 ml of hypotonie Hanks' solution containing 1.5% bovine serum albumin, 0.02 mol/1 HEPES, and 0.5 mmol/1 3-isobutyl-1-methylxanthine (9 
Bioassay of TSH
Addition of extracts from the standard serum (1.0 to 10 mU/1) into the culture medium resulted in significant increases in the levels of cAMP released from the cultured FRTL-5 cells (Fig. 1) . The levels of cAMP in the medium incubated with extracts from standard serum with 1.0 mU/1 were signifi¬ cantly higher than those with no TSH, as measured by triplicate determinations (Fig. 1) . Therefore, the minimum detectable concentration of TSH in the standard serum was considered to be about 1.0 mU/1. Serial dilutions of the sera, obtained from normal subjects, yielded curves parallel to the standard curve (Fig. 2) . Addition of 5 and 10 mU/1 of standard TSH to two sera of normal subjects gave 119 and 91% of the calculated TSH equivalent Relationships between the bioactivities of TSH and immunoreactivities of TSH in normal subjects (A) and in patients with chronic renal failure receiving hemodialysis (B) . The (15, 16) . Therefore, the bioactivities determined in the present bioassay were considered to reflect the bio¬ activities of whole serum TSH.
In patients with severe nonthyroidal illnesses the TSH concentrations are usually within the nor¬ mal range despite low serum thyroid hormone concentrations (2) . In the present study, the bioac¬ tivities of TSH in patients with chronic renal failure were not reduced as compared with those in normal subjects, suggesting that reduced biol¬ ogical activities of TSH are not responsible for de¬ creased thyroid hormone concentrations in these patients.
The present bioassay for TSH is thus sensitive and practical, and the bioactivities of TSH in pa¬ tients with chronic renal failure are considered to be similar to those in normal subjects.
